## **Core Concept**
The question revolves around the treatment of bacterial meningitis caused by gram-negative diplococci, likely *Neisseria meningitidis*, in a patient with a beta-lactam allergy. The core concept here involves understanding the alternative antibiotics used in such cases and their mechanisms of action.

## **Why the Correct Answer is Right**
The correct answer, , involves an antibiotic that inhibits protein synthesis by binding to the bacterial ribosome. This mechanism is crucial for treating infections caused by gram-negative bacteria, especially in patients allergic to beta-lactams. The drug in question is likely a fluoroquinolone or another class that fits this mechanism, given the context of treating gram-negative infections.

## **Why Each Wrong Option is Incorrect**
- **Option A:** If this option involves a mechanism that is not relevant to inhibiting bacterial protein synthesis or cell wall synthesis (e.g., interfering with DNA replication in a way not applicable to the immediate treatment of bacterial meningitis), it would be incorrect.
- **Option B:** Similarly, if this option does not align with an effective mechanism against gram-negative bacteria in a beta-lactam allergic patient, it would be incorrect.
- **Option D:** This option would be incorrect if it describes a mechanism not applicable to the treatment of the described infection, especially considering the need for an alternative to beta-lactams.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that in cases of beta-lactam allergy, especially with severe infections like meningitis, fluoroquinolones or certain antibiotics like ciprofloxacin (which works by inhibiting DNA gyrase and topoisomerase IV) can be considered for gram-negative coverage. However, the use of such antibiotics must be balanced against potential side effects and resistance patterns.

## **Correct Answer: C.**